newsfilter
← Latest News
PR Newswire·

Evofem Biosciences Announces Financial Results for the Second Quarter of 2023

— On track to achieve third consecutive year of revenue growth – — Second consecutive quarter of favorable net product sales to sales and marketing expense ratio — — Reduced total operating expenses 68% — — Decreased